Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study (Q64047066)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study |
clinical trial |
Statements
CERTAIN (English)
0 references
A Phase IIIB, Multi-center, Double-blind, Placebo-controlled, Parallel Group, 52-week Study to Evaluate the Safety and Efficacy of Certolizumab Pegol, Administered With DMARDs, in Patients With Low to Moderate Disease Activity Rheumatoid Arthritis (English)
0 references
June 2008
0 references
May 2010
0 references
194
0 references
18 year
0 references